Invention Grant
- Patent Title: Methods of preventing inflammation and treating pain using anti-NGF compositions
-
Application No.: US13308831Application Date: 2011-12-01
-
Publication No.: US09783601B2Publication Date: 2017-10-10
- Inventor: Leon F. Garcia-Martinez , Benjamin H. Dutzar , Ethan W. Ojala , Jeffrey T. L. Smith , John A. Latham
- Applicant: Leon F. Garcia-Martinez , Benjamin H. Dutzar , Ethan W. Ojala , Jeffrey T. L. Smith , John A. Latham
- Applicant Address: US NV Las Vegas
- Assignee: ALDERBIO HOLDINGS LLC
- Current Assignee: ALDERBIO HOLDINGS LLC
- Current Assignee Address: US NV Las Vegas
- Agency: LeClairRyan, A Professional Corporation
- Agent Robin L. Teskin
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/22 ; A61K51/10 ; C07K16/28 ; A61K45/06 ; A61K39/00
Abstract:
Monovalent agents, including Fab fragments and monovalent monoclonal antibodies analogous to MetMab, having binding specificity to human Nerve Growth Factor (“NGF”), and methods treating pain in an individual wherein there is no substantial increase in the inflammatory response of the individual following administration of the monovalent agents.
Public/Granted literature
- US20120141484A1 METHODS OF PREVENTING INFLAMMATION AND TREATING PAIN USING ANTI-NGF COMPOSITIONS Public/Granted day:2012-06-07
Information query
